Agalsidase beta is a recombinant form of human α-galactosidase A and is produced by recombinant DNA technology using a mammalian Chinese Hamster Ovary (CHO) cell culture. The amino acid sequence of the recombinant form, as well as the nucleotide sequence which encoded it, are identical to the natural form of α-galactosidase.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Agalsidase beta is the active ingredient of these drugs:
Austria Brazil Canada Cyprus Finland
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):